FDAnews
www.fdanews.com/articles/81055-lam-ipm-wound-gel-tm-receives-costa-rican-government-sales-and-marketing-clearance

LAM IPM WOUND GEL(TM) RECEIVES COSTA RICAN GOVERNMENT SALES AND MARKETING CLEARANCE

September 21, 2005

LAM Pharmaceutical, Corp. (OTC BB: LAMP -- News; Frankfurt: LAM -- News; Berlin: LAM -- News), a biomedical company focused on the development and commercialization of novel wound healing and transdermal drug delivery systems, announced today that Ministerio de Salud Republica Costa Rica, Direccion de Registros y Controles (Ministry of Health, Republic of Costa Rica, Directorate of Registrations and Controls) granted LAM Pharmaceutical a clearance to market and sell its patented and proprietary LAM IPM Wound Gel(TM) in Costa Rica, under the registration code DRC-19902.

Yahoo News (http://biz.yahoo.com/prnews/050921/ukw006.html?.v=28)